|
Volumn 95, Issue 4, 2014, Pages 370-372
|
Pharmacotherapy in cancer patients with HIV/AIDS
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
COBICISTAT;
INTEGRASE STRAND TRANSFER INHIBITOR;
MARAVIROC;
NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
UNCLASSIFIED DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANTIRETROVIRAL THERAPY;
ANTIVIRAL THERAPY;
ARTICLE;
CANCER PATIENT;
CANCER THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIVER FUNCTION;
PRIORITY JOURNAL;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTI-HIV AGENTS;
ANTINEOPLASTIC AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG INTERACTIONS;
HIV INFECTIONS;
HUMANS;
LIFE EXPECTANCY;
NEOPLASMS;
|
EID: 84897024689
PISSN: 00099236
EISSN: 15326535
Source Type: Journal
DOI: 10.1038/clpt.2014.10 Document Type: Article |
Times cited : (20)
|
References (4)
|